Literature DB >> 12804853

Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study.

J Díez-Domingo1, J Aristegui, F Calbo, J Gonzalez-Hachero, F Moraga, J Peña Guitian, J Ruiz Contreras, A Torrellas.   

Abstract

The epidemiology and burden of varicella was assessed through the prospective study of 683 children under 15 years, by 58 primary care paediatricians working on seven autonomous communities of Spain. The mean age was 4.5+/-2.7 years, and 566 (83%) were secondary cases. There were 111 complications in 101 children (14.8%), skin superinfection being the most frequent (8.9%), followed by respiratory tract (4.5%) and eye (2.2%) infections. The mean number of visits to the paediatric clinic was 1.42 (95% C.I. 1.37-1.47), and 5.6% of the children were attended in the emergency department of a hospital previously. All children had at least one prescription, being antihistamines and antipyretics the most prescribed. Thirteen percent received systemic antibiotics and 11% acyclovir. Children were mainly cared by grandparents, and parents were off work for a mean of 0.97 days (1.61 if children under 5 years attended day-care facilities; 0.51 if they did not). Costs derived from medical attention totalled 32.5, and social indirect costs were 63.77.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804853     DOI: 10.1016/s0264-410x(03)00264-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

2.  The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey.

Authors:  Judith H Wolleswinkel-van den Bosch; Anouk M Speets; Hans C Rümke; Pearl D Gumbs; Sander C Fortanier
Journal:  BMC Infect Dis       Date:  2011-11-17       Impact factor: 3.090

3.  Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015.

Authors:  Z Meszner; Z Molnar; E Rampakakis; H K Yang; B J Kuter; Lara J Wolfson
Journal:  BMC Infect Dis       Date:  2017-07-14       Impact factor: 3.090

4.  Indirect costs associated with skin infectious disease in children: a systematic review.

Authors:  Irene Lizano-Díez; Jesús Naharro; Ilonka Zsolt
Journal:  BMC Health Serv Res       Date:  2021-12-11       Impact factor: 2.655

5.  Economic burden of varicella in Europe in the absence of universal varicella vaccination.

Authors:  Manjiri Pawaskar; Estelle Méroc; Salome Samant; Elmira Flem; Goran Bencina; Margarita Riera-Montes; Ulrich Heininger
Journal:  BMC Public Health       Date:  2021-12-21       Impact factor: 3.295

Review 6.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

7.  Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.

Authors:  Jacek Wysocki; Ilona Malecka; Joanna Stryczynska-Kazubska; Emmanouil Rampakakis; Barbara Kuter; Lara J Wolfson
Journal:  BMC Public Health       Date:  2018-03-27       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.